Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies-Reference-Cited by-同舟云学术

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

Published:2010-06 Issue:6 Volume:11 Page:530-542
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Publisher

Elsevier BV

Subject

Oncology

Reference60 articles.

1. Insulin and insulin-like growth factor signalling in neoplasia;Pollak;Nat Rev Cancer,2008

2. The role of the IGF system in cancer growth and metastasis: overview and recent insights;Samani;Endocr Rev,2007

3. Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture;Furlanetto;Cancer Res,1984

4. Presence of somatomedin receptors on primary human breast and colon carcinomas;Pollak;Cancer Lett,1987

5. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer;Peyrat;Eur J Cancer,1993

Cited by 525 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge mapping of metformin use on cancers: a bibliometric analysis (2013–2023);Frontiers in Pharmacology;2024-08-13

2. Childhood growth hormone treatment: challenges, opportunities, and considerations;The Lancet Child & Adolescent Health;2024-08

3. Non-genetic factors and breast cancer: an umbrella review of meta-analyses;BMC Cancer;2024-07-26

5. Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view;Journal of Endocrinological Investigation;2024-06-27